Detalles de la búsqueda
1.
[A Case of Advanced Breast Cancer with Hypercalcemia and No Bone Metastasis Treated with Multidisciplinary Therapy].
Gan To Kagaku Ryoho
; 47(13): 2150-2152, 2020 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-33468890
2.
[A Case of Recurrent Breast Cancer with Contralateral Axillary Node Recurrence Cured after Mastectomy for Ipsilateral Breast Tumor Recurrence].
Gan To Kagaku Ryoho
; 46(13): 2018-2020, 2019 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-32157045
3.
A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06).
Int J Clin Oncol
; 19(1): 68-73, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23314924
4.
Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.
Int J Clin Oncol
; 18(3): 547-53, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22588780
5.
Randomized phase II study of three doses of oral TAS-108 in postmenopausal patients with metastatic breast cancer.
Cancer Sci
; 103(9): 1708-13, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22676245
6.
[Efficacy of oxycodone against anti-cancer agent-induced pain in breast cancer patients during adjuvant treatment before and after surgery].
Gan To Kagaku Ryoho
; 38(7): 1137-42, 2011 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-21772098
7.
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.
Breast Cancer Res Treat
; 121(1): 121-31, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20339913
8.
True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment.
Breast J
; 16(2): 127-33, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20030655
9.
[Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial].
Gan To Kagaku Ryoho
; 37(1): 57-63, 2010 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-20087033
10.
Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03).
Breast Cancer Res Treat
; 107(1): 87-94, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18043897
11.
Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.
Breast Cancer
; 14(1): 16-24, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17244989
12.
[Collaboration between oncologist and family physicians for the use of a regional cooperation booklet].
Nihon Rinsho
; 70 Suppl 7: 785-91, 2012 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-23350505
13.
Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients.
Breast Cancer
; 13(2): 159-65, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16755111
14.
Combination docetaxel and trastuzumab treatment for patients with HER-2-overexpressing metastatic breast cancer: a multicenter, phase-II study.
Breast Cancer
; 13(2): 166-71, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16755112
15.
Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer.
Breast Cancer
; 13(2): 179-85, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16755114
16.
[Present conditions and future of ambulatory treatment and home care for breast cancer].
Gan To Kagaku Ryoho
; 33(5): 595-8, 2006 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-16685154
17.
[A phase-I clinical study of a combination therapy of vinorelbine and capecitabine in patients with advanced/recurrent breast cancer].
Gan To Kagaku Ryoho
; 33(8): 1091-7, 2006 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-16912527
18.
[Multicenter phase II trial of thrice-weekly docetaxel and weekly trastuzumab as preoperative chemotherapy in patients with HER 2-overexpressing breast cancer--Japan East Cancer Center Breast Cancer Consortium (JECBC) 02 Trial].
Gan To Kagaku Ryoho
; 33(10): 1411-5, 2006 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-17033229
19.
[Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients].
Gan To Kagaku Ryoho
; 32(3): 335-9, 2005 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-15791816
20.
Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients.
Oncol Rep
; 10(4): 833-7, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12792731